annual accounts payable:
$10.03M-$3.47M(-25.68%)Summary
- As of today (August 22, 2025), PRCT annual accounts payable is $10.03 million, with the most recent change of -$3.47 million (-25.68%) on December 31, 2024.
- During the last 3 years, PRCT annual accounts payable has risen by +$8.00 million (+394.43%).
- PRCT annual accounts payable is now -25.68% below its all-time high of $13.50 million, reached on December 31, 2023.
Performance
PRCT Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$11.78M-$3.04M(-20.53%)Summary
- As of today (August 22, 2025), PRCT quarterly accounts payable is $11.78 million, with the most recent change of -$3.04 million (-20.53%) on June 30, 2025.
- Over the past year, PRCT quarterly accounts payable has increased by +$1.83 million (+18.42%).
- PRCT quarterly accounts payable is now -21.90% below its all-time high of $15.09 million, reached on September 30, 2024.
Performance
PRCT quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PRCT Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.7% | +18.4% |
| 3 y3 years | +394.4% | +252.6% |
| 5 y5 years | +594.7% | - |
PRCT Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.7% | +394.4% | -21.9% | +252.6% |
| 5 y | 5-year | -25.7% | +709.0% | -21.9% | +850.2% |
| alltime | all time | -25.7% | +709.0% | -21.9% | +850.2% |
PRCT Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $11.78M(-20.5%) |
| Mar 2025 | - | $14.83M(+47.8%) |
| Dec 2024 | $10.03M(-25.7%) | $10.03M(-33.5%) |
| Sep 2024 | - | $15.09M(+51.6%) |
| Jun 2024 | - | $9.95M(-1.3%) |
| Mar 2024 | - | $10.08M(-25.3%) |
| Dec 2023 | $13.50M | $13.50M(-0.7%) |
| Sep 2023 | - | $13.60M(+35.5%) |
| Jun 2023 | - | $10.04M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $10.34M(+10.1%) |
| Dec 2022 | $9.39M(+362.8%) | $9.39M(+48.3%) |
| Sep 2022 | - | $6.33M(+89.4%) |
| Jun 2022 | - | $3.34M(+27.2%) |
| Mar 2022 | - | $2.63M(+29.5%) |
| Dec 2021 | $2.03M(+63.6%) | $2.03M(-43.5%) |
| Sep 2021 | - | $3.59M(+7.3%) |
| Jun 2021 | - | $3.35M(+169.9%) |
| Dec 2020 | $1.24M(-14.1%) | $1.24M |
| Dec 2019 | $1.44M | - |
FAQ
- What is PROCEPT BioRobotics Corporation annual accounts payable?
- What is the all time high annual accounts payable for PROCEPT BioRobotics Corporation?
- What is PROCEPT BioRobotics Corporation annual accounts payable year-on-year change?
- What is PROCEPT BioRobotics Corporation quarterly accounts payable?
- What is the all time high quarterly accounts payable for PROCEPT BioRobotics Corporation?
- What is PROCEPT BioRobotics Corporation quarterly accounts payable year-on-year change?
What is PROCEPT BioRobotics Corporation annual accounts payable?
The current annual accounts payable of PRCT is $10.03M
What is the all time high annual accounts payable for PROCEPT BioRobotics Corporation?
PROCEPT BioRobotics Corporation all-time high annual accounts payable is $13.50M
What is PROCEPT BioRobotics Corporation annual accounts payable year-on-year change?
Over the past year, PRCT annual accounts payable has changed by -$3.47M (-25.68%)
What is PROCEPT BioRobotics Corporation quarterly accounts payable?
The current quarterly accounts payable of PRCT is $11.78M
What is the all time high quarterly accounts payable for PROCEPT BioRobotics Corporation?
PROCEPT BioRobotics Corporation all-time high quarterly accounts payable is $15.09M
What is PROCEPT BioRobotics Corporation quarterly accounts payable year-on-year change?
Over the past year, PRCT quarterly accounts payable has changed by +$1.83M (+18.42%)